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The case report by Rajagopalan and Booth demonstrates successful long-term
LVAD support of a patient with a mechanical mitral valve. The continuous flow
from the left atrium to the left ventricle and into the inflow of the LVAD appears to
provide sufficient washing of the Bjork-Shiley mechanical valve surfaces and
avoid thrombosis. The higher level of anticoagulation used in this case may not
have been needed, and in some patients this may have complicated
gastrointestinal bleeding.
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Heart valve abnormalities are common in patients with advanced stage heart
failure who are candidates for left ventricular assist device (LVAD) support. Valve
abnormalities during LVAD support can alter both filling and emptying of the
device, resulting in a reduced level of cardiac support. Concurrent valvular
procedures are now performed in approximately 20% of patients undergoing
LVAD implantation (1, 2). Many of these patients have had prior placement of a
prosthetic valve and are usually more ill than the average LVAD recipient at the
time of implant, with a higher risk for postoperative complications and mortality.
Careful consideration for handling preexisting prosthetic valves at the time of
LVAD implant is vital for good outcome.

Aortic Valve Considerations
Continuous-flow LVADs unload the left ventricle and eject blood via an outflow
graft attached to the ascending aorta throughout the entire cardiac cycle. This left
ventricular bypass causes the aortic valve to be either closed or to have

The VAD Journal: http://dx.doi.org/10.13023/VAD.2015.05

Page 1 of 3

The VAD Journal: The journal of mechanical assisted circulation and heart failure
	
  
	
  
	
  
shortened opening time. Mechanical aortic valves are highly susceptible to
thrombosis in this environment, and intermittent opening of the valve increases
the risk of thromboembolism. Patients with preexisting mechanical aortic valves
should have the valve oversewn or replaced with a bioprosthetic at time of LVAD
implantation. The disadvantages of bioprosthetic valve use are the additional
cardiopulmonary bypass time for placement and the possibility of leaflet fusion. A
patch sewn to the annulus prevents the valve from functioning and there is a risk
of subvalvular thrombus formation and embolization (3). Another potential
disadvantage of the oversewn aortic outlet is in the case of pump stoppage; the
depressed left ventricle would need to generate sufficient force to pump blood
through the LVAD and its conduits, which may not be possible in some patients.
The current recommendation by the 2013 International Society of Heart Lung
Transplantation Guidelines for Mechanical Circulatory Support is to oversew the
aortic valve in patients supported for bridge to transplant, and replacement of the
mechanical valve with a bioprosthetic for those supported for destination therapy
or those who are likely to have myocardial recovery (4). Patients presenting for
LVAD implant with a properly functioning bioprosthetic aortic valve do not require
surgical intervention. However, there are reports that thrombosis, pannus
development, and complete fusion of the leaflets have occurred during LVAD
support (5, 6).

Mitral Valve Consideration
The mitral valve will normally remain open due to the high flow rate into the
LVAD. This high flow is believed to be adequate for washout and has a low risk
of thrombosis for both mechanical and bioprosthetic valves (7). Due to the
technical difficulty of replacing the mitral valve, and the low risk of thrombotic
problems, current recommendations are to leave prosthetic mitral valve in place
and consider increased anticoagulation. However, there is no evidence that
increased anticoagulation is necessary, and some patients have done well
without any anticoagulation with a mechanical valve in the mitral position during
LVAD support (8).
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